Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Two demyelinating diseases in the brain of a single patient, PML and MS: how to minimize 'one' while treating the 'other'.
[Vaccines and central nervous system demyelinating diseases: New studies on the internet –not just new rumors].
Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter.
Multiple sclerosis: getting personal with induced pluripotent stem cells.
Best Practices in Alemtuzumab Administration: Practical Recommendations for Infusion in Patients With Multiple Sclerosis.
The Roles of Vitamin D and Its Analogs in Inflammatory Diseases.
Reply to Letter to Editor - Distal acquired demyelinating symmetric neuropathy associated with colorectal adenocarcinoma:Should it be termed paraneoplastic?
Anti-CD20 antibody wows in multiple sclerosis.
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis.
Identifying employed multiple sclerosis patients at-risk for job loss: When do negative work events pose a threat?
Preferences of Patients With Multiple Sclerosis for Attributes of Disease Modifying Drugs In Decision-Making: A Nominal Group Technique And Best-Worst Scaling.
Molecular interplay between T-Antigen and splicing factor, arginine/serine-rich 1 (SRSF1) controls JC virus gene expression in glial cells.
Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels.
A case of multiple sclerosis and celiac disease.
White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
Cuprizone-Induced Demyelination as a Tool to Study Remyelination and Axonal Protection.
The cooling effect on proinflammatory cytokines interferon-gamma, tumor necrosis factor-alpha, and nitric oxide in patients with multiple sclerosis.
Extracellular Acidic pH Inhibits Oligodendrocyte Precursor Viability, Migration, and Differentiation.
Circulating CD56(dim) NK cells expressing perforin are increased in progressive multiple sclerosis.
Implicit memory in multiple sclerosis.
XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis.
Oligodendrogenesis in the normal and pathological central nervous system.
Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis.
Finding benefit in stressful uncertain circumstances: relations to social support and stigma among women with unexplained illnesses.
Poster Abstracts from the Fourth International Symposium on Gait and Balance in Multiple Sclerosis: The Role of CognitionCleveland Clinic • Cleveland, Ohio, USA • October 10 & 11, 2014.
Pages
« first
‹ previous
…
516
517
518
519
520
521
522
523
524
…
next ›
last »